[1]周志航,王建国,丁厚鹏.活血通痹汤联合富血小板血浆治疗膝骨性关节炎54例[J].中国中医骨伤科杂志,2022,30(01):61-64.
　ZHOU Zhihang,WANG Jianguo,DING Houpeng.Study of Efficacy of Huoxue Tongbi Decoction Combined with Platelet Rich Plasma on the Treatment of Knee Osteoarthritis[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2022,30(01):61-64.
点击复制

活血通痹汤联合富血小板血浆治疗膝骨性关节炎54例()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第30卷
期数:
2022年01期
页码:
61-64
栏目:
临床报道
出版日期:
2022-01-15

文章信息/Info

Title:
Study of Efficacy of Huoxue Tongbi Decoction Combined with Platelet Rich Plasma on the Treatment of Knee Osteoarthritis
文章编号:
1005-0205(2022)01-0061-04
作者:
周志航1; 王建国1; 丁厚鹏1
1山东青州市中医院(山东 青州,262500)
Author(s):
ZHOU Zhihang1; WANG Jianguo1; DING Houpeng1
1Qingzhou Hospital of Traditional Chinese Medicine,Qingzhou 262500,Shandong China.
关键词:
活血通痹汤;  富血小板血浆;  膝骨性关节炎;  炎症因子
Keywords:
Huoxue Tongbi decoction;  platelet rich plasma(PRP);  knee osteoarthritis;  inflammatory factor
分类号:
R684.3
文献标志码:
B
摘要:
目的:观察活血通痹汤联合富血小板血浆治疗膝骨性关节炎(KOA)的临床疗效及对关节液中白介素-1β(IL-1β)、白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)的影响。方法:选取2018年7月至2020年6月收治的54例膝骨性关节炎患者,给予活血通痹汤口服联合自体富血小板血浆关节腔内注射(PRP)治疗,分别在治疗前、治疗后6周,采用数字评价量表评分(NRS)进行疼痛分析、膝关节损伤与骨关节炎评分(KOOS)进行膝关节疗效评估,参考《中药新药临床研究指导原则》制定中医症状评分,并观察患者关节液中IL-1β、IL-6、TNF-α水平变化。结果:54例患者治疗后NRS评分、KOOS评分、中医症状评分、炎症因子水平均较治疗前明显改善,差异有统计学意义(P<0.05)。结论:活血通痹汤联合富血小板血浆对膝骨性关节炎疗效显著,能降低关节液中炎症因子的表达,是治疗膝骨性关节炎的有效方法。
Abstract:
Objective:To observe the efficacy of Huoxue Tongbi decoction combined with platelet rich plasma(PRP)on knee osteoarthritis and its effects on interleukin-1β(IL-1β),interleukin-6(IL-6)and tumor necrosis factor-α(TNF-α).Methods:54 KOA patients during July 2018 to June 2020 were administrated with Huoxue tongbi decoction combined with platelet rich plasma.Before and 6 weeks after treatment,respectively,the pain was analyzed by digital rating scale(NRS); knee joint injury and osteoarthritis score(KOOS)was used to evaluate the efficacy of knee joint; TCM symptom score was made according to the guiding principles of clinical research of new Chinese medicine,and the levels of IL-1β,IL-6,TNF-α in patients' joint fluid were observed.Results:54 patients in NRS,KOOS,TCM symptom score and inflammatory factor were significantly improved than that before treatment(P<0.05),and it had statistical significance.Conclusion:Huoxue Tongbi decoction combined with PRP has satisfied efficacy on the treatment of knee osteoarthritis and effectively reduce the levels of inflammatory factors in synovia,which is an effective treatment for KOA.

参考文献/References:

[1] 马良彧,王善正,郭玉冬,等.富血小板血浆治疗骨性关节炎的现状[J].中国矫形外科杂志,2018,26(15):1396-1399.
[2] 中国医疗保健国际交流促进会骨科分会.关节腔注射富血小板血浆治疗膝骨关节炎的临床实践指南(2018年版)[J].中华关节外科杂志(电子版),2018,12(4):444-448.
[3] 成帅,胡振勇,陈连锁,等.不同中医证型膝关节骨关节炎患者血清IL-6、TNF-α水平及关节疼痛程度比较[J].山东医药,2019,59(26):82-84.
[4] 中华医学会骨科学分会关节外科学组.骨关节炎诊疗指南(2018年版)[J].中华骨科杂志,2018,38(12):705-715.
[5] 国家食品药品监督管理局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出社版,2002:349-353.
[6] 林璐璐,孙宁.膝关节骨性关节炎常用评价量表的比较与分析[J].中国疼痛医学杂志,2018,24(2):135-139.
[7] 屠建锋,王丽琼,石广霞,等.针刺对膝骨关节炎患者膝关节损伤与膝关节炎评分的影响[J].中国针灸,2021,41(1):27-30.
[8] 赵露婷,王剑雄,方其林,等.富血小板血浆治疗膝骨关节炎的研究进展[J].重庆医学,2018,47(16):2216-2222.
[9] AMABLE P R,CARIAS R B,TEIXEIRA M V,et al.Platelet-rich plasma preparation for regenerative medicine:optimization and quantification of cytokines and growth factors[J].Stem Cell Res Ther,2013,4(3):67.
[10] 福嘉欣,王树森.自体富血小板血浆治疗骨关节与运动损伤疾病的机制与应用[J].中国组织工程研究,2017,21(30):4909-4915.
[11] 庞成龙,颜世昌,陈晖.富血小板血浆治疗膝骨性关节炎的研究进展[J].骨科,2019,10(2):167-172.
[12] 陈玉泉,洪建明,徐俊,等.不同浓度富血小板血浆修复膝关节软骨损伤的疗效对比[J].医学理论与实践,2019,32(10):1550-1551.
[13] 王加俊,匡志平,卢卫忠,等.富血小板血浆注射治疗膝骨关节炎疗效观察[J].广东医学,2016,37(21):3266-3269.
[14] 凌华俊,林伟文.比较富血小板血浆及透明质酸对临床患者膝关节炎模型中炎症因子IL-1、TNF-α表达的影响[J].检验医学与临床,2020,17(19):2780-2783.
[15] 胡军,周中.温阳通痹汤内服联合乌花透骨汤熏洗治疗退行性膝关节炎临床疗效观察[J].中华中医药学刊,2019,17(10):2394-2397.
[16] 陈星,高文飞.阳和汤联合玻璃酸钠关节腔内注射治疗膝关节骨性关节炎临床研究[J].新中医,2018,50(6):112-114.
[17] 李治锋,朱卓然,龚泰芳,等.加味阳和汤联合塞来昔布治疗老年膝骨性关节炎临床疗效及对患者血清TNF-α、IL-β的影响[J].四川中医,2019,37(2):158-161.
[18] 张晨,马建强.加味阳和汤对膝骨性关节炎病患MMP-3、MMP-9水平的影响研究[J].陕西中医,2016,37(2):201-203.
[19] 高伟华,李玉杰,杨鸿冉,等.加味阳和汤对不同时期膝骨关节炎兔关节软骨结构的影响[J].中国中医骨伤科杂志,2019,27(5):7-13
[20] 杨黎黎,王庆甫,王欢,等.通络止痛方对人膝骨关节炎关节液IL-1β,HA及NO的影响[J].中国中医骨伤科杂志,2017,25(1):1-4.
[21] 林晓航,唐剑邦,吴宇峰,等.关节镜清理术联合关节内注射透明质酸钠对膝骨关节炎患者TNF-α、IL-6和IL-1β的影响[J].国际检验医学杂志,2017,38(23):3335-3337.
[22] 任海亮,马剑雄,马信龙.膝骨关节炎时关节滑液中炎症相关物质的表达[J].中国组织工程研究,2015,19(15):2336-2340.
[23] FRYER A D,JACOBY D B,WICHER S A.Protective role of eosinophils and TNF-α after ozone inhalation[J].Res Rep Health Eff Inst,2017,3(191):1-41.
[24] 段大波,张数鹰.透明质酸联合塞来昔布治疗骨性关节炎的效果及对TNF-α、IL-1β、PGE2的影响[J].医学综述,2016,22(23):4729-4732.
[25] 陈根强,许慧娟,汪志明.等,骨性关节炎患者中血清与关节液的炎性因子水平变化及意义[J].武汉大学学报(医学版),2014,35(1):110-113.

备注/Memo

备注/Memo:
基金项目:潍坊市卫生健康委员会中医药科研项目(2020-4-073)
更新日期/Last Update: 2022-01-18